GLP‑1 patients get DEXA scans
- Hone Health said on April 14 it is integrating BodySpec’s dual-energy X-ray absorptiometry, or DEXA, scans into its telehealth platform for patients using glucagon-like peptide-1 weight-loss drugs and other longevity programs. - Patients can buy a scan in the Hone app, review results in the platform, and discuss fat, lean mass, visceral fat, bone density, and resting metabolic rate with clinicians. - The push follows rising concern that GLP-1 weight loss can include muscle loss, shifting monitoring beyond scale weight alone. (medcitynews.com)
Hone Health is adding BodySpec DEXA scans to its telehealth platform so patients on GLP-1 drugs can track what kind of weight they are losing. (honehealth.com) (medcitynews.com) DEXA stands for dual-energy X-ray absorptiometry, a low-dose scan that breaks the body into fat, lean tissue, and bone instead of showing only a single number on a scale. BodySpec says its scans also report visceral fat and bone density in under 15 minutes. (bodyspec.com 1) (bodyspec.com 2) Hone announced the partnership on April 14, 2026. The company said patients will be able to purchase a BodySpec scan through the Hone app, see the results inside Hone’s platform, and review them with a clinician. (honehealth.com) (mobihealthnews.com) The immediate use case is GLP-1 treatment, where doctors want to know whether falling weight reflects fat loss, muscle loss, or both. MedCity News reported that Hone plans to use the scans to help evaluate how the drugs are affecting patients’ bodies. (medcitynews.com) (honehealth.com) That matters because a bathroom scale cannot tell whether 10 pounds lost came from fat or lean mass. BodySpec says DEXA can measure body fat, lean mass, visceral fat, and bone density with clinical-grade precision. (bodyspec.com 1) (bodyspec.com 2) Hone said the integrated reports can be used alongside hormone and metabolic markers so clinicians can adjust treatment earlier. The company framed the move as part of a broader push to combine lab testing, imaging, and physician review in one care workflow. (honehealth.com) (prnewswire.com) BodySpec says it has completed more than 600,000 scans over 13 years, and its booking page lists appointments in cities including Austin, Boston, Chicago, Dallas, Denver, Los Angeles, San Diego, San Francisco, San Jose, and Seattle. (bodyspec.com 1) (bodyspec.com 2) The commercial pitch is straightforward: move obesity and longevity care away from weight alone and toward body-composition tracking. For GLP-1 patients, that means the next check-in may be a scan, not just a scale. (medcitynews.com) (honehealth.com)
